Skip to Content
Search Menu

Mirikizumab As a Potential New Treatment in Patients with Crohn’s Disease

Mirikizumab is approved for the treatment of ulcerative colitis. The main objective of the VIVID 1 study was to evaluate the efficacy and the safety of mirikizumab in patients with moderate to severe Crohn’s disease. The results show significant efficacy vs placebo and that mirikizumab also will have its place in patients with Crohn’s disease regardless whether it’s a patient who previously failed or did not fail a biological therapy.
Marc Ferrante

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

Jonas Julius Rudbæk

Unidentified Trigger can Prompt Pathological Changes Many Years Prior to Clinical Onset of Crohn’s Disease and Colitis Ulcerosa

/ Jonas Julius Rudbæk
CrohnsIBDUlcerative colitis Play the Video 13:37
Abhinav Vasudevan

Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

/ Abhinav Vasudevan
CrohnsIBDUlcerative colitis Play the Video 06:43
Maiara Brusco De Freitas

Impaired Growth and Nutritional Status Can Be Observed Several Years Before Diagnosis of Childhood-Onset IBD

/ Maiara Brusco De Freitas
CrohnsIBDUlcerative colitis Play the Video 6:10
Thea Wiken

Vedolizumab and Ustekinumab as Treatment for Patients with Ulcerative Colitis

/ Thea Helm Wiken
ECCO24Ulcerative colitis Play the Video 5:52

Increased Incidence of Comorbid Diseases 10 Years Prior to IBD Diagnosis

/ Anthony C. Ebert
ECCO24IBD Play the Video 6:47
Gorm Roager Madsen

Periodontitis Seems to Be Linked to Increased IBD Disease Activity and Disability

/ Gorm Roager Madsen
ECCO24IBD Play the Video 4:05
Daniele Noviello

Risankizumab Downregulates IL-23-Induced Mucosal Pathogenic Th17 Cells in Patients with Crohn’s Disease

/ Daniele Noviello
CrohnsECCO24 Play the Video 5:49
Anja Poulsen

Colon Involvement or Isolated Small Intestinal Resection is Associated with a Higher Risk of Re-Resection in Crohn’s Disease Patients

/ Anja Poulsen
CrohnsECCO24 Play the Video 04:49
Joana Revés

No Association Between Bowel Damage and Disability in Patients with Recently Diagnosed Crohn’s Disease

/ Joana Revés
CrohnsECCO24 Play the Video 06:52
Back to top